Increasing number of people suffering from anaphylaxis and diabetes across the globe, technological advancements in autoinjectors, and rising preference for self-administration of drugs are some key factors expected to drive global Autoinjectors market growth.
Increasing number of people suffering from anaphylaxis and diabetes across the globe, technological advancements in autoinjectors, and rising preference for self-administration of drugs are some key factors expected to drive global Autoinjectors market growth.
According to Emergen Research, the global autoinjectors market size was USD 45.89 billion in 2020 and is expected to reach USD 170.16 billion in 2028 and register a robust CAGR of 17.7% during the forecast period, 2021-2028.
Market Dynamics:
An autoinjector is a self-injectable medical device used for delivering a dose of a particular drug through subcutaneous or intramuscular route. The autoinjector is useful for rapid administration of the drug or antidotes and is widely used due to its reliability, simplicity, and ability to be administered directly by a patient who is not medically trained. This makes it very convenient for mass casualty management or emergencies such as exposure to nerve gas, anaphylaxis, migraine, diabetes, pesticide poisoning, and other medical conditions that require immediate drug administration. Factors such as increasing elderly population, rising incidence of chronic and autoimmune diseases, increasing number of regulatory approvals, and growing inclination towards home care settings are expected to drive global market revenue growth during the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/678
In addition, increasing focus on introducing the next generation of autoinjectors, rapid adoption of advanced autoinjectors in emergency conditions, and growing inclination towards telehealth services and home care settings are expected to drive global market growth. However, rising preference for alternative routes of drug delivery, rapid adoption of nasal epinephrine sprays, and high chances of needlestick injuries due to improper handling of devices are some key factors that can hamper overall market growth to a certain extent during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Disposable Segment To Register Rapid Revenue CAGR:
The disposable segment revenue is expected to expand at a rapid CAGR between 2021 and 2028. This can be attributed to factors such as increasing prevalence of various chronic conditions, rising elderly population, and more preference for disposable autoinjectors due to low risk of infection and contamination, easy usage, and availability.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/678
Home Care Settings Segment to Account for Largest Revenue Share:
The home care settings segment is expected to account for largest revenue share during the forecast period owing to large patient pool, rising geriatric population, rising preference for telehealth, rapid adoption of home healthcare devices, and availability of user-friendly autoinjectors for home use.
North America to Lead In Terms of Revenue Share:
North America is expected to account for largest revenue share in the global market during the forecast period owing to high prevalence of diabetes, cancer, multiple sclerosis, psoriasis, and anaphylaxis across the region, rapid advancements in auto-injectors, and increasing awareness about the benefits of autoinjectors. Other factors such as increasing geriatric population, growing inclination towards home care settings, high disposable income, and rising investments in developing more effective products are expected to fuel North America market growth during the forecast period.
Major Companies in the Market Include:
- Braun Melsungen AG
- AbbVie Inc.
- Mylan
- Eli Lilly and Company
- Ypsomed
- Amgen
- Becton, Dickinson and Company
- GlaxoSmithKline plc
- Johnson & Johnson
- Antares Pharma
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/autoinjectors-market
For the purpose of this report, Emergen Research has segmented the global autoinjectors market based on therapy, type, route of administration, end-use, and region:
Therapy Outlook (Revenue, USD Billion; 2018–2028)
- Rheumatoid Arthritis
- Multiple Sclerosis
- Anaphylaxis
- Diabetes
- Others
Type Outlook (Revenue, USD Billion; 2018–2028)
- Disposable
- Reusable
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)
- Subcutaneous
- Intramuscular
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home Care Settings
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/678
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Related Published Articles Published by Emergen Research:
Prenatal Testing and Newborn Screening Market
Unmanned Ground Vehicle Market
Farm Management Software and Services Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-autoinjectors-market